BE898649A - Resinate d'un acide carboxylique substitue, procedes pour sa preparation, son utilisation et compositions pharmaceutiques le contenant - Google Patents

Resinate d'un acide carboxylique substitue, procedes pour sa preparation, son utilisation et compositions pharmaceutiques le contenant Download PDF

Info

Publication number
BE898649A
BE898649A BE0/212185A BE212185A BE898649A BE 898649 A BE898649 A BE 898649A BE 0/212185 A BE0/212185 A BE 0/212185A BE 212185 A BE212185 A BE 212185A BE 898649 A BE898649 A BE 898649A
Authority
BE
Belgium
Prior art keywords
resinate
sep
formula
resin
pharmaceutical compositions
Prior art date
Application number
BE0/212185A
Other languages
English (en)
French (fr)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of BE898649A publication Critical patent/BE898649A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE0/212185A 1983-01-12 1984-01-11 Resinate d'un acide carboxylique substitue, procedes pour sa preparation, son utilisation et compositions pharmaceutiques le contenant BE898649A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH14783A CH655507B (enExample) 1983-01-12 1983-01-12

Publications (1)

Publication Number Publication Date
BE898649A true BE898649A (fr) 1984-07-11

Family

ID=4180317

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212185A BE898649A (fr) 1983-01-12 1984-01-11 Resinate d'un acide carboxylique substitue, procedes pour sa preparation, son utilisation et compositions pharmaceutiques le contenant

Country Status (41)

Country Link
US (1) US4510128A (enExample)
EP (1) EP0122219B1 (enExample)
JP (1) JPS59134759A (enExample)
KR (1) KR900006747B1 (enExample)
AR (1) AR240310A1 (enExample)
AT (2) AT391467B (enExample)
AU (1) AU570230B2 (enExample)
BE (1) BE898649A (enExample)
CA (1) CA1218077A (enExample)
CH (1) CH655507B (enExample)
CS (1) CS269954B2 (enExample)
DD (1) DD218373A5 (enExample)
DE (2) DE3474152D1 (enExample)
DK (1) DK166683B1 (enExample)
DZ (1) DZ593A1 (enExample)
EG (1) EG16562A (enExample)
ES (1) ES8504849A1 (enExample)
FI (1) FI82682C (enExample)
FR (1) FR2542735B1 (enExample)
GB (1) GB2134529B (enExample)
GR (1) GR79793B (enExample)
HK (1) HK90390A (enExample)
HU (1) HU190750B (enExample)
IE (1) IE56545B1 (enExample)
IL (1) IL70660A (enExample)
IT (1) IT1177501B (enExample)
LU (1) LU85171A1 (enExample)
MA (1) MA20000A1 (enExample)
MC (1) MC1564A1 (enExample)
MT (1) MTP943B (enExample)
NL (1) NL8400098A (enExample)
NO (1) NO162862C (enExample)
NZ (1) NZ206815A (enExample)
OA (1) OA07628A (enExample)
PH (1) PH21795A (enExample)
PL (1) PL142737B1 (enExample)
PT (1) PT77932B (enExample)
RO (1) RO88481A (enExample)
SE (1) SE457959B (enExample)
ZA (1) ZA84212B (enExample)
ZW (1) ZW484A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona
US5230885A (en) * 1987-12-23 1993-07-27 Smith Kline & French Laboratories Limited Polystyrene anion exchange polymer pharmaceutical composition
AU608114B2 (en) * 1987-12-23 1991-03-21 Smith Kline & French Laboratories Limited Compounds
GB8730010D0 (en) * 1987-12-23 1988-02-03 Smith Kline French Lab Compounds
CH675537A5 (enExample) * 1988-03-25 1990-10-15 Ciba Geigy Ag
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
EP0373103B1 (de) * 1988-11-10 1993-03-31 Ciba-Geigy Ag Flüssige orale Formulierung
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8911719D0 (en) * 1989-05-22 1989-07-05 Smith Kline French Lab Compounds
GB8913699D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
GB8913700D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
SE9004129D0 (sv) * 1990-12-21 1990-12-21 Pharmacia Lkb Biotech Anion exchanger
JPH06509099A (ja) * 1991-07-03 1994-10-13 サノ・コーポレーシヨン ジクロフエナツクの経皮デリバリーに対する組成物及び方法
EP1250937B1 (en) * 2001-04-09 2009-05-13 Rohm And Haas Company Controlled dissolution of active ingredients
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
RU2221559C1 (ru) * 2002-11-15 2004-01-20 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Препарат диклофенак натрия длительного действия
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
WO2006061700A2 (en) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
ATE536867T1 (de) 2006-03-16 2011-12-15 Tris Pharma Inc Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
US7799347B2 (en) * 2006-09-07 2010-09-21 Chondrex Inc. Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases
EP2352568B1 (en) * 2008-10-02 2017-11-29 University of Pittsburgh - Of the Commonwealth System of Higher Education Administration of an adsorbent polymer for treatment of systemic inflammation
MX391660B (es) 2010-03-24 2025-03-21 Jazz Pharmaceuticals Inc Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
BR112021006027A2 (pt) 2018-11-19 2021-06-29 Jazz Pharmaceuticals Ireland Limited formulações de fármaco resistente a álcool
BR112021013766A2 (pt) 2019-03-01 2021-09-21 Flamel Ireland Limited Composições de gama-hidroxibutirato com farmacocinética melhorada no estado alimentado
TW202139986A (zh) 2020-02-21 2021-11-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 治療原發性嗜睡症之方法
US12582622B2 (en) 2020-10-08 2026-03-24 Jazz Pharmaceuticals Ireland Limited Sodium oxybate to treat idiopathic hypersomnia
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
CN121038779A (zh) 2023-02-03 2025-11-28 特瑞斯制药公司 每晚一次的低钠羟丁酸盐组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857193A (en) * 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
GB823000A (en) * 1957-10-03 1959-11-04 Clinical Products Ltd Resin-drug compounds
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3316282A (en) * 1965-02-08 1967-04-25 Squibb & Sons Inc Anion exchange resin complex of a cycloborate ester of a steroid
FI49600C (fi) * 1967-12-20 1975-08-11 Ciba Geigy Ag Menetelmä substituoitujen fenyylietikkahappojen ja näiden suolojen val mistamiseksi.
CH519476A (de) * 1968-03-30 1972-02-29 Hoechst Ag Verfahren zur Herstellung von Salzen von Acylamino-alkylbenzolsulfonyl-harnstoffen mit Anionenaustauschern
US3926864A (en) * 1971-06-21 1975-12-16 Ionics Ion exchange membranes having a macroporous surface area
GB1423694A (en) * 1973-07-10 1976-02-04 Beecham Group Ltd Pharmaceutical compositions
US4058491A (en) * 1975-02-11 1977-11-15 Plastomedical Sciences, Inc. Cationic hydrogels based on heterocyclic N-vinyl monomers
FR2352547A1 (fr) * 1976-05-25 1977-12-23 Viridis Ets Nouvelle resine anionique a action hypocholesterolemiante, son procede de preparation et compositions therapeutiques la contenant
US4217421A (en) * 1977-06-27 1980-08-12 Rohm And Haas Company Anion exchange resins prepared from crosslinked polystyrenesulfonylchloride
US4380590A (en) * 1978-09-19 1983-04-19 Rohm And Haas Company Emulsion copolymer cation exchange resins
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
US4207399A (en) * 1979-03-14 1980-06-10 Rohm And Haas Company Methylquinoline high polymer based on quaternary ammonium polymers
US4302548A (en) * 1980-05-22 1981-11-24 Rohm And Haas Company Production of ion exchange resins, the resins so produced and ion exchange processes using them

Also Published As

Publication number Publication date
DE3474152D1 (en) 1988-10-27
DK11884A (da) 1984-07-13
CS17884A2 (en) 1989-10-13
CH655507B (enExample) 1986-04-30
SE457959B (sv) 1989-02-13
JPS59134759A (ja) 1984-08-02
HUT34151A (en) 1985-02-28
IT8447527A0 (it) 1984-01-10
SE8400098L (sv) 1984-07-13
HU190750B (en) 1986-10-28
FI82682C (fi) 1991-04-10
SE8400098D0 (sv) 1984-01-10
ZA84212B (en) 1984-08-29
FR2542735B1 (fr) 1986-04-18
EP0122219A3 (en) 1985-05-08
OA07628A (fr) 1985-05-23
IL70660A0 (en) 1984-04-30
DK11884D0 (da) 1984-01-11
FR2542735A1 (fr) 1984-09-21
AU2323084A (en) 1984-07-19
NO840090L (no) 1984-07-13
ATE37378T1 (de) 1988-10-15
PT77932B (en) 1986-07-22
GB8400251D0 (en) 1984-02-08
JPH0257058B2 (enExample) 1990-12-03
IT1177501B (it) 1987-08-26
ES528770A0 (es) 1985-05-01
ES8504849A1 (es) 1985-05-01
AT391467B (de) 1990-10-10
IE56545B1 (en) 1991-08-28
PH21795A (en) 1988-02-29
KR840007562A (ko) 1984-12-08
EG16562A (en) 1991-12-30
CA1218077A (en) 1987-02-17
MC1564A1 (fr) 1984-11-12
GB2134529B (en) 1986-09-24
ATA784A (de) 1990-04-15
IT8447527A1 (it) 1985-07-10
LU85171A1 (de) 1984-10-24
ZW484A1 (en) 1984-08-08
FI840069A0 (fi) 1984-01-09
MA20000A1 (fr) 1984-10-01
PL142737B1 (en) 1987-11-30
DK166683B1 (da) 1993-06-28
AU570230B2 (en) 1988-03-10
KR900006747B1 (ko) 1990-09-20
PL245656A1 (en) 1985-01-02
NL8400098A (nl) 1984-08-01
MTP943B (en) 1984-06-05
NO162862C (no) 1990-02-28
CS269954B2 (en) 1990-05-14
DE3400491A1 (de) 1984-07-12
IE840049L (en) 1984-07-12
DE3400491C2 (enExample) 1988-11-10
NO162862B (no) 1989-11-20
DZ593A1 (fr) 2004-09-13
FI82682B (fi) 1990-12-31
EP0122219B1 (de) 1988-09-21
EP0122219A2 (de) 1984-10-17
HK90390A (en) 1990-11-09
NZ206815A (en) 1986-08-08
US4510128A (en) 1985-04-09
GB2134529A (en) 1984-08-15
IL70660A (en) 1987-08-31
FI840069A7 (fi) 1984-07-13
AR240310A1 (es) 1990-03-30
DD218373A5 (de) 1985-02-06
GR79793B (enExample) 1984-10-31
PT77932A (en) 1984-02-01
RO88481A (ro) 1986-01-30

Similar Documents

Publication Publication Date Title
MC1564A1 (fr) Resinate d'un acide carboxylique substitue,procedes pour sa preparation,son utilisation et compositions pharmaceutiques le contenant
BE1015217A5 (enExample)
EP0016702B1 (fr) Médicament, notamment pour le traitement du choléra, et compositions pharmaceutiques le contenant
EP2349217A1 (fr) Nouvelle composition à base d'acide gamma-hydroxybutyrique
BE904899A (fr) Compositions therapeutiques flottantes a degagement progressif.
BE897311A (fr) Composition medicale contenant du pirprofen
MC1101A1 (fr) Composition a activite retardee
EP1615632B1 (fr) Formulations orales flottantes pour la liberation controlee de la betaine
FR2904774A1 (fr) Composition pharmaceutique solide contenant une combinaison d'un agent regulateur de la motilite intestinale et d'un antiflatulent.
BE1001706A3 (fr) Forme d'administration solide, a desagregation rapide, du diclofenac.
FR2540727A1 (fr) Nouvelle preparation retard contenant de la n''-cyano-n-4-pyridyl-n'-1,2,2-trimethylpropylguanidine, utile notamment dans le traitement de l'hypertension
MC1280A1 (fr) Preparation de formules pharmaceutiques de gommes de polysaccharides
NO159697B (no) Fremgangsmaate ved fremstilling av nye komplekser av carrageenan og emepron, doxycyclin eller propranolol.
FR2620334A1 (fr) Composition pour l'administration orale contenant du magnesium et du potassium
CH664284A5 (en) Chloroquine medicaments without bitter taste - contain complex of chloroquine with copolymer of methacrylic] acid and methyl methacrylate]
FR2548537A1 (enExample)
CA2624494C (fr) Comprimes orodispersibles de principes actifs amers
CA1163923A (fr) Procede d'enrobage d'au moins un principe actif medicamenteux
FR2620332A1 (fr) Composition pharmaceutique a forte teneur en medicament, et procede pour la preparer
FR2484253A1 (fr) Comprime de theophylline a liberation prolongee
CA1227136A (fr) Compositions pharmaceutiques contenant a titre de principe actif l'acide 4-(benzofuran-2-yl)4-oxo buten-2-oique et/ou de ses sels pharmaceutiquement acceptables
BE839604A (fr) Composition a activite retardee
CA2022447A1 (fr) Forme galenique orale ameliorant la biodisponibilite
BE897823A (fr) Medicament exercant une activite anti-ulcereuse, spasmolytique et anesthesique locale
BE818172A (fr) Compositions contenant des antibiotiques a cycle beta-lactame.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CIBA-GEIGY A.G.

Effective date: 19940131